Thromb Haemost 1960; 4(02): 234-243
DOI: 10.1055/s-0038-1654501
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Athrombia Thrombocytopathica

Seref Inceman
1   Second Gynecology and Obstetric Clinic, Second and Third Internal Clinics of Istanbul University, Guraba Hospital, Istanbul, Turkey
,
Sami Uçar
1   Second Gynecology and Obstetric Clinic, Second and Third Internal Clinics of Istanbul University, Guraba Hospital, Istanbul, Turkey
,
Orhan Nuri Ulutin*
1   Second Gynecology and Obstetric Clinic, Second and Third Internal Clinics of Istanbul University, Guraba Hospital, Istanbul, Turkey
› Author Affiliations
Further Information

Publication History

Publication Date:
17 June 2018 (online)

Preview

Summary

The authors reported a primary congenital thrombocytopathy in a case of erythroblastosis foetalis born with a hemorrhagic diathesis. The case was followed from the day of birth through the 2nd year. The boy presented the picture of Willebrand-Jürgens type thrombopathy (primary thrombocytopathy) with some characteristics of this disease. The agglomeration and adhesivity of the platelets were defective. These were corrected in physiological salt solution and polyvinyl pyrolidon. Although the platelets contained the thromboplastic factor, it was not given into the media under normal conditions. The biochemical and morphological osmotic resistance revealed increased platelet resistance in hypotonic salt solutions. The increased resistance and the delay in the platelet disintegration were also observed in the study of the viscous metamorphosis by the phase contrast microscope. Consequently, in this case there was a platelet stability. The authors discussed the characteristics of this case and compared some of their findings with similar cases in the literature.

* Dr. Seref Inceman, Assistant Professor, Department of Haematology, Third Internal Clinic of Istanbul University, Istanbul, Turkey; Dr. Sami Uçar, Paediatrician in Second Gynecology and Obstetric Clinic of Istanbul University, Istanbul, Turkey; Dr. Orhan Nuri Ulutin, Research Associate in Departments of Haematology and Coagulation, Henry Ford Hospital, Detroit, Michigan; Departments of Haematology and Coagulation, Second Internal Clinic of Istanbul University, Istanbul, Turkey.